Therapy rounds
4therapeutic areas explored
Work area by area
We built a landscape of biomarkers and detection technologies for each area of interest.
Case Study · Technology Landscape
Diagnostics beyond blood and urine.
A global pharmaceutical leader wanted to find non-invasive biomarkers that could power new diagnostic devices. We mapped emerging biomarkers and detection technologies by therapeutic area and introduced it to a promising platform developer.
The Client
The client is one of the global leaders in the pharmaceutical industry. It wanted a map of emerging opportunities and potential partners in digital and wearable biomarkers.
The Challenge
Beyond blood.
Find the next biofluid.
Prescouter was asked to explore early-stage non-invasive biomarkers detected in alternative biofluids such as sweat, saliva and interstitial fluid, and the developers advancing them toward new diagnostic devices.
-
Biofluids
Sweat, saliva and more
Beyond blood, urine and CSF.
-
Stage
Preclinical to early trials
Early-stage developments only.
-
Partners
Emerging developers
Potential collaborators mapped.
Our Approach
Building a landscape for each therapeutic area.
Records analysis
4record types analyzed
Mine the evidence
We analyzed scientific literature, patents, startup data and clinical trial records.
Platform pick
1platform technology selected
Find the platform
We selected a platform able to support diagnostics across multiple biomarkers and disease areas.
The Outcome
One platform, many biomarkers.
Prescouter found that the non-invasive biomarker space has grown rapidly over the past 5 years, with a strong shift toward wearables. We pinpointed the biofluid with the best balance of potential and evidence, selected a versatile platform technology and brokered introductions with its developers.
-
Trend
5 years of growth
Led by wearable technologies.
-
Biofluid
The best balance
Of potential and established evidence.
-
Partner
1 platform technology
Introduced to the client team.
Non-invasive diagnostics are moving fast, but evidence matters as much as novelty. The best bets balance promise with proof.
Let’s Talk
What could your next diagnostic detect?
Let’s map the science and partners behind your next diagnostic. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]